Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment. (Q46648287)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Y Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Y Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

L Yao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Y Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

T Ouyang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

T Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Z Fan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

T Fan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

B Lin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

L He

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

P Li

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Y Xie

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

11 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1423-1429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407954%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen: a most unlikely pioneering medicine

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Pharmacodynamic and biological effects of anti-estrogens in different models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Cytochrome P450 pharmacogenetics and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Analysis of tamoxifen and its metabolites in synthetic gastric fluid digests and urine samples using high-performance liquid chromatography with electrospray mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN155